CL-ACP: a parallel combination of CNN and LSTM anticancer peptide recognition model

BACKGROUND: Anticancer peptides are defence substances with innate immune functions that can selectively act on cancer cells without harming normal cells and many studies have been conducted to identify anticancer peptides. In this paper, we introduce the anticancer peptide secondary structures as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huiqing, Zhao, Jian, Zhao, Hong, Li, Haolin, Wang, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527680/
https://www.ncbi.nlm.nih.gov/pubmed/34670488
http://dx.doi.org/10.1186/s12859-021-04433-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527680/
https://www.ncbi.nlm.nih.gov/pubmed/34670488
http://dx.doi.org/10.1186/s12859-021-04433-9

Ejemplares similares